ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months' period ended 31st December, 2020 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee. In terms of Regulation 47 of the Listing Regulations, please find enclosed herewith, copies of the Notices of the Board Meeting published in newspapers, viz., Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) today, i.e., on 18th January, 2021.

Astec Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

Please find enclosed herewith, Compliance Certificate received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited, for the Quarter ended December 31, 2020, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Tejashree PradhanDesignation :- Company Secretary and Compliance Officer

This is to inform you that as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from Friday, 1st January, 2021 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine Months ending 31st December, 2020. Accordingly all Officers and Designated Persons (including Directors and Auditors) of the Company have been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.

This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.

This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok V Hiremath

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith disclosure on Related Party Transactions for the Half Year ended September 30, 2020 on a consolidated basis, drawn in accordance with the applicable Accounting Standards.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok V Hiremath